Which 2018 MIPS CQMs do you support?

Clinigence supports all EHR-based MIPS measures.

Clinigence supports all registry MIPS measures.

Anti-platelet Medication for High Risk Patients2018-06-28T02:16:08-04:00

The percentage of high risk patients who are prescribed an dication. High risk patients include those patients ages 50-69 years with ≥ 10% 10-year CVD risk

Avoiding Use of CNS Depressants in Patients on Long-Term Opioids2018-06-28T02:44:15-04:00

The percentage of patients on long-term opioid prescriptions without a concurrent prescription for an CNS depressant

Back Pain: Use of EMG & CNS2018-06-28T02:40:36-04:00

Percentage of patients with a diagnosis of axial lumbar, thoracic or cervical spine pain who had an electromyography (EMG) or nerve conduction study (NCS) within 30 days of the diagnosis

Cancer Patients – Survivorship Care Plan2018-06-28T02:41:27-04:00

Percentage of patients with an encounter for follow-up examination after completed treatment for malignant neoplasm who have a survivorship care plan documented on the same date

Chronic Kidney Disease (CKD): eGFR Monitoring2018-06-28T02:37:28-04:00

The percentage of adult patients with Stage 3 or 4 CKD who have had a eGFR or serum creatinine in the past 6 months

Chronic Kidney Disease (CKD): Hemoglobin Monitoring2018-06-28T02:38:33-04:00

The percentage of adult patients with Stage 3B-Stage 5 CKD who have had a serum hemoglobin measured in the past 12 months

Foot Bone Infection Diagnosis Without MRI2018-06-28T02:45:02-04:00

Percentage of patients with a diagnosis of bone infection (osteomyelitis) in the foot who had an MRI of the foot.

Goal Setting and Attainment for Cancer Survivors2018-06-28T02:42:22-04:00

Percentage of patients aged 18 years and older who completed the final component of cancer treatment that have at least one post-treatment goal documented and progress of goal attainment documented within 12 months of completing the final component of cancer treatment.

Monitoring Serum Creatinine2018-06-28T02:39:18-04:00

The percentage of adult patients prescribed an ACEI, ARB, digoxin, diuretic or metformin who have had a serum creatinine measured in the past 12 months

Morton’s Neuroma – Avoidance of Alcohol Injections2018-06-28T02:46:09-04:00

Percentage of patients with a diagnosis of Morton’s neuroma who received alcohol injections

NSAID or Cox 2 Inhibitor Use in Patients with Heart Failure (HF), Hypertension (HTN), or Chronic Kidney Disease (CKD)2018-06-28T02:07:31-04:00

The percentage of adult patients with HF, HTN or CKD who are not prescribed an NSAID or COX 2 inhibitor.

Screening for albuminuria in patients at risk for CKD (DM and/or HTN)2018-06-28T02:36:13-04:00

Test for albuminuria or urine protein in adults with Diabetes Mellitus or Hypertension and without CKD

Screening for Type 2 Diabetes2018-06-28T02:24:40-04:00

The percentage of patients 40 to 70 years of age who are overweight or obese and have been screened for type 2 diabetes in the past 3 years

By |2018-09-07T01:06:16-04:00June 28th, 2018||Comments Off on Which 2018 MIPS CQMs do you support?